Role of proteases, cytokines, and growth factors in bone invasion by oral squamous cell carcinoma

키워드

참고문헌 (50)

1. Jacques Ferlay, "Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012", International Journal of Cancer, 136(5), pp.E359~E386 (2015), Wiley[DOI]
2. Saman Warnakulasuriya, "Global epidemiology of oral and oropharyngeal cancer", Oral Oncology, 45(4-5), pp.309~316 (2009), Elsevier BV[DOI]
3. EIJIRO JIMI, "The RANKL", RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma, 2013, pp.42(3), 803~809[DOI]
4. Esra Attar, "Head and neck cancer in a developing country: A population-based perspective across 8years", Oral Oncology, 46(8), pp.591~596 (2010), Elsevier BV[DOI]
5. S. Choi, "Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy", Journal of Dental Research, 87(1), pp.14~32 (2008), SAGE Publications[DOI]
6. Stefano Petti, "Lifestyle risk factors for oral cancer", Oral Oncology, 45(4-5), pp.340~350 (2009), Elsevier BV[DOI]
7. James S. Brown, "Patterns of invasion and routes of tumor entry into the mandible by oral squamous cell carcinoma", Head & Neck, 24(4), pp.370~383 (2002), Wiley[DOI]
8. E Jimi, "The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma", Oral Diseases, 17(5), pp.462~468 (2011), Wiley[DOI]
9. Joshua E. Lubek, "Evaluation of the Bone Margin in Oral Squamous Cell Carcinoma", Oral and Maxillofacial Surgery Clinics of North America, 29(3), pp.281~292 (2017), Elsevier BV[DOI]
10. Masahiro Ito, "Jaw bone remodeling at the invasion front of gingival squamous cell carcinomas", Journal of Oral Pathology and Medicine, 32(1), pp.10~17 (2003), Wiley[DOI]
11. Richard J. Shaw, "The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma", Head & Neck, 26(10), pp.861~869 (2004), Wiley[DOI]
12. Liza J. Raggatt, "Cellular and Molecular Mechanisms of Bone Remodeling", Journal of Biological Chemistry, 285(33), pp.25103~25108 (2010), American Society for Biochemistry & Molecular Biology (ASBMB)[DOI]
13. S. Georges, "Proteases and bone remodelling", Cytokine & Growth Factor Reviews, 20(1), pp.29~41 (2009), Elsevier BV[DOI]
14. Julia K.L. Woodward, "The roles of proteolytic enzymes in the development of tumour-induced bone disease in breast and prostate cancer", Bone, 41(6), pp.912~927 (2007), Elsevier BV[DOI]
15. Stephen M. Krane, "Matrix metalloproteinases and bone", Bone, 43(1), pp.7~18 (2008), Elsevier BV[DOI]
16. N. Fazil Erdem, "Characterization of 3 Oral Squamous Cell Carcinoma Cell Lines With Different Invasion and", or Metastatic Potentials, 2007, pp.65(9), 1725~1733[DOI]
17. Hui-Ching Chuang, "Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma", Modern Pathology, 21(12), pp.1444~1450 (2008), Springer Science and Business Media LLC[DOI]
18. S. Thiolloy, "Osteoclast-Derived Matrix Metalloproteinase-7, but Not Matrix Metalloproteinase-9, Contributes to Tumor-Induced Osteolysis", Cancer Research, 69(16), pp.6747~6755 (2009), American Association for Cancer Research (AACR)[DOI]
19. Conor C. Lynch, "MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL", Cancer Cell, 7(5), pp.485~496 (2005), Elsevier BV[DOI]
20. Jingjing Quan, "Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms", Cancer and Metastasis Reviews, 31(1-2), pp.209~219 (2012), Springer Science and Business Media LLC[DOI]
21. Vasilena Gocheva, "Cysteine Cathepsins and the Cutting Edge of Cancer Invasion", Cell Cycle, 6(1), pp.60~64 (2014), Informa UK Limited[DOI]
22. Oakley C. Olson, "Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response", Nature Reviews Cancer, 15(12), pp.712~729 (2015), Springer Science and Business Media LLC[DOI]
23. Goto T, "Cathepsins in the osteoclast", J Electron Microsc(Tokyo), 52, pp.551~558 (2003)[DOI]
24. Hitoshi Kawamata, "Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines", International Journal of Cancer, 70(1), pp.120~127 (1997), Wiley[DOI]
25. Goro Kawasaki, "Cathepsin expression in oral squamous cell carcinoma: Relationship with clinicopathologic factors", Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 93(4), pp.446~454 (2002), Elsevier BV[DOI]
26. William J. Boyle, "Osteoclast differentiation and activation", Nature, 423(6937), pp.337~342 (2003), Springer Science and Business Media LLC[DOI]
27. Chelsea K. Martin, "Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma", Oral Oncology, 48(6), pp.491~499 (2012), Elsevier BV[DOI]
28. Takayama Y, "Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma", International Journal of Oncology, 36(6), pp.1387~1394 (2010), Spandidos Publications[DOI]
29. William C. Dougall, "The RANK", RANKL, Cancer and Metastasis Reviews, pp.2007, 25(4)[DOI]
30. David L. Cochran, "Inflammation and Bone Loss in Periodontal Disease", Journal of Periodontology, 79(8 Suppl), pp.1569~1576 (2008), Wiley[DOI]
31. Eijiro Jimi, "NF-κB acts as a multifunctional modulator in bone invasion by oral squamous cell carcinoma", Oral Science International, 13(1), pp.1~6 (2016), Wiley[DOI]
32. Tomoki Nakashima, "The dynamic interplay between osteoclasts and the immune system", Archives of Biochemistry and Biophysics, 473(2), pp.166~171 (2008), Elsevier BV[DOI]
33. Zvi Bar-Shavit, "The osteoclast: A multinucleated, hematopoietic-origin, bone-resorbing osteoimmune cell", Journal of Cellular Biochemistry, 102(5), pp.1130~1139 (2007), Wiley[DOI]
34. Dewhirst FE, "Purification and partial sequence of human osteoclastactivating factor : identity with interleukin 1 beta", J Immunol, 135, pp.2562~2568 (1985)
35. Matthew C. Walsh, "OSTEOIMMUNOLOGY: Interplay Between the Immune System and Bone Metabolism", Annual Review of Immunology, 24(1), pp.33~63 (2006), Annual Reviews[DOI]
36. Nabanita S. Datta, "PTH and PTHrP signaling in osteoblasts", Cellular Signalling, 21(8), pp.1245~1254 (2009), Elsevier BV[DOI]
37. Fabiana N Soki, "The multifaceted actions of PTHrP in skeletal metastasis", Future Oncology, 8(7), pp.803~817 (2012), Future Medicine Ltd[DOI]
38. Swagatika Panda, "Chemokines accentuating protumoral activities in oral cancer microenvironment possess an imperious stratagem for therapeutic resolutions", Oral Oncology, 60, pp.8~17 (2016), Elsevier BV[DOI]
39. R. Daniel Bonfil, "Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis", Urologic Oncology: Seminars and Original Investigations, 25(5), pp.407~411 (2007), Elsevier BV[DOI]
40. Stan Gronthos, "The role of the chemokine CXCL12 in osteoclastogenesis", Trends in Endocrinology & Metabolism, 18(3), pp.108~113 (2007), Elsevier BV[DOI]
41. Y Sambandam, "CXCL13 activation of c-Myc induces RANK ligand expression in stromal", preosteoblast cells in the oral squamous cell carcinoma tumor–bone microenvironment, 2013, pp.32(1), 97~105[DOI]
42. S. Yuvaraj, "A Novel Function of CXCL13 to Stimulate RANK Ligand Expression in Oral Squamous Cell Carcinoma Cells", Molecular Cancer Research, 7(8), pp.1399~1407 (2009), American Association for Cancer Research (AACR)[DOI]
43. Subramanya N.M. Pandruvada, "Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice", International Journal of Cancer, 126, pp.2319~2329 (2009), Wiley[DOI]
44. Erika Oue, "CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction", Biochemical and Biophysical Research Communications, 424(3), pp.456~461 (2012), Elsevier BV[DOI]
45. Koichi Matsuo, "Osteoclast–osteoblast communication", Archives of Biochemistry and Biophysics, 473(2), pp.201~209 (2008), Elsevier BV[DOI]
46. Goda T, "Bone destruction by invading oral squamous carcinoma cells mediated by the transforming growth factor-beta signalling pathway", Anticancer Res, 30, pp.2615~2623 (2010)
47. V PAPADIMITRAKOPOULOU, "The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis", Cancer Letters, 239(1), pp.136~143 (2006), Elsevier BV[DOI]
48. M. Partridge, "Expression of bFGF, KGF and FGF receptors on normal oral mucosa and SCC", European Journal of Cancer Part B: Oral Oncology, 32(2), pp.76~82 (1996), Elsevier BV[DOI]
49. Jingjing Quan, "Transforming growth factor-β1 treatment of oral cancer induces epithelial-mesenchymal transition and promotes bone invasion via enhanced activity of osteoclasts", Clinical & Experimental Metastasis, 30(5), pp.659~670 (2013), Springer Science and Business Media LLC[DOI]
50. Gao J, "TGF-β promotes invasion and angiogenesis of oral squamous cell carcinoma SCC9cells by upregulation of slug signal", Int J Clin Exp Pathol, 10, pp.5325~5333 (2017)

관련 논문AI추천